COPANLISIB AND VOLASERTIB OVERCOME IBRUTINIB‐VENETOCLAX RESISTANCE VIA TARGETING PI3K‐AKT SIGNALING AND G2/M CELL CYCLE TRANSITION IN MANTLE CELL LYMPHOMA

Saved in:
Bibliographic Details
Published inHematological oncology Vol. 37; no. S2; pp. 126 - 127
Main Authors Zhang, R., Lee, W., Huang, S., Liu, Y., Leeming, A.H., McIntosh, J.M., Nomie, K.J., Jiang, C.V., Wang, M.
Format Journal Article
LanguageEnglish
Published Chichester Wiley Subscription Services, Inc 01.06.2019
Subjects
1-Phosphatidylinositol 3-kinase
AKT protein
Cell cycle
Lymphoma
Mantle cell lymphoma
Targeted cancer therapy
Online AccessGet full text

Cover

More Information
ISSN:0278-0232
1099-1069
DOI:10.1002/hon.86_2629